申请人:SCHNEIDER Siegfried
公开号:US20140073621A1
公开(公告)日:2014-03-13
The present invention encompasses compounds of general formula (1)
wherein
R
1
to R
3
are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
本发明涵盖了一般式(1)中定义为权利要求1中所述的R1至R3的化合物,适用于治疗由过度或异常细胞增殖特征的疾病,并且用于制备具有上述特性的药物。